Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants.
Altered natural killer cells' response to herpes virus infection in multiple sclerosis involves KIR2DL2 expression.
Pediatric Multiple Sclerosis.
Peroxisome proliferator-activated receptor (PPAR)α and -γ regulate IFNγ and IL-17A production by human T cells in a sex-specific way.
Tenascins and inflammation in disorders of the nervous system.
The long-term cost-effectiveness of the use of Functional Electrical Stimulation for the correction of dropped foot due to upper motor neuron lesion.
The treatment of spasticity with Delta9-tetrahydrocannabinol in persons with spinal cord injury.
Interferon β-1a therapy for multiple sclerosis during pregnancy: an unresolved issue.
Substance Name: ONO 4641
Type 1 immune response in progressive multiple sclerosis.
Dok2 mediates the CD200Fc attenuation of Abeta-induced changes in glia.
Immune responses in rapidly progressive dementia: a comparative study of neuroinflammatory markers in Creutzfeldt-Jakob disease, Alzheimer¿s disease and multiple sclerosis.
Alemtuzumab Therapy for Multiple Sclerosis.
Cyclophosphamide in chronic progressive multiple sclerosis: a comparative study.
Multifocal and pattern-reversal visual evoked potentials vs. automated perimetry frequency-doubling technology matrix in optic neuritis.
Glutamate inhibition in MS: the neuroprotective properties of riluzole.
Modulation of CNS autoimmune responses by CD8(+) T cells coincides with their oligoclonal expansion.
[American Academy of Neurology, Washington, 18-25 April 2015].
Intrauterine environment and multiple sclerosis: a population- based case-control study.
A nurse-led mental health service for people with multiple sclerosis.
Evaluating treatment effect within a multivariate stochastic ordering framework: Nonparametric combination methodology applied to a study on multiple sclerosis.
Neurologic complications of influenza.
Evidence for a two-stage disability progression in multiple sclerosis.
[New treatment options in multiple sclerosis and their complications].
Cerebrospinal fluid analysis.

Pages